NeuroScientific hails 80% clinical response in Crohn’s stem cell program | Collector
The Age
NeuroScientific hails 80% clinical response in Crohn’s stem cell program
NeuroScientific Biopharmaceuticals has reported an 80% response rate from five Crohn’s disease patients treated with its StemSmart cell therapy, with all patients showing improvement.
The Age